ICON (Ivermectin in COvid Nineteen) study: Use of Ivermectin is Associated with Lower Mortality in Hospitalized Patients with COVID19

Juliana Cepelowicz Rajter, Michael S. Sherman, Naaz Fatteh, Fabio Vogel, Jamie Sacks, Jean-Jacques Rajter
doi: https://doi.org/10.1101/2020.06.06.20124461

Article Information

doi 
https://doi.org/10.1101/2020.06.06.20124461
History 
  • June 10, 2020.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Juliana Cepelowicz Rajter, M.D.1,
  2. Michael S. Sherman, M.D.2,
  3. Naaz Fatteh, M.D.1,
  4. Fabio Vogel, Pharm. D., BCPS1,
  5. Jamie Sacks, Pharm. D.1 and
  6. Jean-Jacques Rajter, M.D.1,3,*
  1. 1Broward Health Medical Center, Fort Lauderdale, FL
  2. 2Emeritus Professor, Drexel University College of Medicine
  3. 3Assistant Professor, Florida International University
  1. ↵*Corresponding author: Jean-Jacques Rajter, MD, covid19{at}pscflorida.com
Back to top
Posted June 10, 2020.
Download PDF
Data/Code
Email
ICON (Ivermectin in COvid Nineteen) study: Use of Ivermectin is Associated with Lower Mortality in Hospitalized Patients with COVID19
Juliana Cepelowicz Rajter, Michael S. Sherman, Naaz Fatteh, Fabio Vogel, Jamie Sacks, Jean-Jacques Rajter
medRxiv 2020.06.06.20124461; doi: https://doi.org/10.1101/2020.06.06.20124461
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area